ANCA-GBM dot-blot: Evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis

Journal of Clinical Immunology

Volumn 24, Issue 4, 2004, Pages 435-440

  Rutgers, Abraham ^a   Damoiseaux, Jan ^a   Roozendaal, Caroline ^b   Limburg, Pieter C ^b   Stegeman, Coen A ^b   Cohen Tervaert, Jan Willem ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

ANCA; GBM; Immunoassay; Myeloperoxidase; Proteinase 3

Indexed keywords

GLOMERULUS BASEMENT MEMBRANE ANTIBODY; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS BASEMENT MEMBRANE; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GLOMERULONEPHRITIS; HUMANS; IMMUNOBLOTTING; MYELOBLASTIN; OBSERVER VARIATION; PEROXIDASE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERINE ENDOPEPTIDASES;

EID: 3442895754     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOCI.0000029115.79266.ae     Document Type: Article

References (23)

1. Hricik DE, Chung-Park M, Sedor JR: Glomerulonephritis. N Engl J Med 339:888-899, 1998
2. Couser WG: Glomerulonephritis. Lancet 353:1509-1515, 1999
3. Johnson JP: Rapidly progressive glomerulonephritis. In Primer on kidney disease, A Greenberg (eds). San Diego, Academic Press, 1994, pp. 94-99
4. Levy JB, Turner AN, Rees AJ, Pusey CD: Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033-1042, 2001
5. Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56:1751-1758, 1999
6. Slot MC, Cohen Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 63:670-677, 2003
7. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A: Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features. Kidney Int 57:846-862, 2000
8. Cohen Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CG: Detection of autoantibodies against myeloid lysosomal enzymes: A useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 91:59-66, 1991
9. Csernok E, Ahlquist D, Ullrich S, Gross WL: A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology (Oxford) 41:1313-1317, 2002
10. Boomsma MM, Stegeman CA, Oost-Kort WW, Kallenberg CG, Moguilevsky N, Limburg PC, Cohen Tervaert JW: Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis. J Immunol Methods 254:47-58, 2001
11. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135:921-930, 1989
12. Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ: Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23-32, 1996
13. Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AE, Kallenberg CG: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 37:799-806, 1990
14. Glassock RJ, Adler SG, Cohen AH: Primary Glomemlar Diseases. In The Kidney (vol 1), BM Brenner, FC Rector (eds). Philadelphia, W.B. Saunders Company, 1991, pp. 1182-1279
15. Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Cohen Tervaert JW: Image analysis: A novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods 274:27-35, 2003
16. Ermens AA, Bayens AJ, Crooymans A, Broekman-Van Hout AA, van Duijnhoven HL: Evaluation of a simple dot-blot method for the detection of anti-neutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase. Clin Chem 46:1717-1719, 2000
17. Short AK, Esnault VL, Lockwood CM: Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis 26:439-445, 1995
18. Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C: Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 8:376-385, 1997
19. Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A, Ingelmo M, Revert L: Prognostic implication of antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 36:107-113, 1991
20. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348:2543-2556, 2003
21. Rutgers A, Heeringa P, Damoiseaux J, Cohen Tervaert JW: ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med 14:287-295, 2003
22. Han WK, Choi HK, Roth RM, McCluskey RT, Niles JL: Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis. Kidney Int 63:1079-1085, 2003
23. Stegeman CA: Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Nephrol Dial Transplant 17:2077-2080, 2002